What happened at AAIC 2017? Be the first to know – Alzheimer’s – Optimum Senior Care – Chicago In Home Caregivers – www.OptimumSeniorcare.com
The Alzheimer’s Association International Conference®2017 (AAIC®) has concluded, and we close this gathering of the field’s leading dementia science researchers with renewed determination to work together to end this disease.
We can – and must – build on this momentum. We all must continue to work together to help the Alzheimer’s Association address the global dementia crisis by providing education and support to the millions who face dementia every day, while advancing vital research toward methods of treatment, prevention and, ultimately, a cure.
Your support today is a symbol of your commitment to continue exploring the important findings announced at this conference, including:
- Brain amyloid PET scans may substantially impact medical management of people with dementia, according to interim results from the Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study, which is led by the Alzheimer’s Association and managed by the American College of Radiology. This data will be submitted to Medicare as supportive evidence for why scans should be covered by Medicare in the future.
- A small but intriguing new study investigated using a blood test for amyloid – a substance that accumulates in the brains of people with Alzheimer’s. Blood tests are simpler than spinal taps and less expensive than PET scans – which is how we currently measure amyloid.
- More than one-third of global dementia cases may be preventable through addressing lifestyle factors, according to The Lancet Commission on Dementia Prevention, Intervention and Care.
Please know that your support makes advances like these possible and provides ongoing care and support for those affected by this devastating disease. For a recap of the highlights from AAIC, read the latest ?updates or watch these videos.
The world’s foremost Alzheimer’s investigators, clinicians and care providers have returned to their important work. Now we must return to ours. Now more than ever, we rely on your support to move forward in this fight.
As we work to change the trajectory of Alzheimer’s disease, we must continue to fight this disease on every front. Thank you for your gift to advance research while providing care and support every day to those affected by Alzheimer’s.